211 related articles for article (PubMed ID: 15256984)
1. Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome.
Janssen HL; van Zonneveld M; van Nunen AB; Niesters HG; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2004 Aug; 16(8):801-7. PubMed ID: 15256984
[TBL] [Abstract][Full Text] [Related]
2. Treatment of polyarteritis nodosa and Churg-Strauss syndrome: indications of plasma exchanges.
Guillevin L; Lhote F
Transfus Sci; 1994 Dec; 15(4):371-88. PubMed ID: 10155556
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine.
Erhardt A; Sagir A; Guillevin L; Neuen-Jacob E; Häussinger D
J Hepatol; 2000 Oct; 33(4):677-83. PubMed ID: 11059878
[TBL] [Abstract][Full Text] [Related]
4. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients.
Guillevin L; Lhote F; Leon A; Fauvelle F; Vivitski L; Trepo C
J Rheumatol; 1993 Feb; 20(2):289-98. PubMed ID: 8097249
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
Kruger M; Böker KH; Zeidler H; Manns MP
J Hepatol; 1997 Apr; 26(4):935-9. PubMed ID: 9126810
[TBL] [Abstract][Full Text] [Related]
6. Successful combination therapy of polyarteritis nodosa associated with a pre-core promoter mutant hepatitis B virus infection.
Wartelle-Bladou C; Lafon J; Trépo C; Pichoud C; Picon M; Pellissier JF; Zoulim F
J Hepatol; 2001 May; 34(5):774-9. PubMed ID: 11434628
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients.
Guillevin L; Mahr A; Callard P; Godmer P; Pagnoux C; Leray E; Cohen P;
Medicine (Baltimore); 2005 Sep; 84(5):313-322. PubMed ID: 16148731
[TBL] [Abstract][Full Text] [Related]
8. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients.
Guillevin L; Lhote F; Cohen P; Sauvaget F; Jarrousse B; Lortholary O; Noël LH; Trépo C
Medicine (Baltimore); 1995 Sep; 74(5):238-53. PubMed ID: 7565065
[TBL] [Abstract][Full Text] [Related]
9. Life-threatening complications of hepatitis B virus-related polyarteritis nodosa developing despite interferon-alpha2b therapy: successful treatment with a combination of interferon, lamivudine, plasma exchanges and steroids.
Deléaval P; Stadler P; Descombes E; Hecker E; Schrago G; Chizzolini C; Nicole A; Pugin P; Regamey C
Clin Rheumatol; 2001; 20(4):290-2. PubMed ID: 11529642
[TBL] [Abstract][Full Text] [Related]
10. HBV-related cutaneous periarteritis nodosa in a patient 16 years after renal transplantation: efficacy of lamivudine.
Bedani PL; Bergami M; Cavazzini PL; Strumia R; Morelli MC; Stabellini G; Gilli P
J Nephrol; 2001; 14(5):428-30. PubMed ID: 11730280
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatitis B virus-related polyarteritis nodosa: two case reports and a review of the literature.
Deeren DH; De Backer AI; Malbrain ML; Verbraeken H; Blockmans D
Clin Rheumatol; 2004 Apr; 23(2):172-6. PubMed ID: 15045636
[TBL] [Abstract][Full Text] [Related]
12. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.
Tangkijvanich P; Komolmit P; Mahachai V; Sa-nguanmoo P; Theamboonlers A; Poovorawan Y
J Clin Virol; 2009 Oct; 46(2):117-23. PubMed ID: 19651540
[TBL] [Abstract][Full Text] [Related]
13. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis.
Trepo C; Guillevin L
J Autoimmun; 2001 May; 16(3):269-74. PubMed ID: 11334492
[TBL] [Abstract][Full Text] [Related]
14. Pre-core mutants of hepatitis B virus in patients receiving immunosuppressive treatment after orthotopic liver transplantation.
Protzer U; Goergen B; Hopf U; Neuhaus P; König V; Meyer zum Büschenfelde KH; Gerken G
J Med Virol; 1996 Oct; 50(2):135-44. PubMed ID: 8915879
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
Liao YP; Jiang JL; Zou WY; Xu DR; Li J
World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
[TBL] [Abstract][Full Text] [Related]
16. Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges.
Guillevin L; Lhote F; Sauvaget F; Deblois P; Rossi F; Levallois D; Pourrat J; Christoforov B; Trépo C
Ann Rheum Dis; 1994 May; 53(5):334-7. PubMed ID: 7912504
[TBL] [Abstract][Full Text] [Related]
17. Analysis of HCV co-infection with occult hepatitis B virus in patients undergoing IFN therapy.
Khattab E; Chemin I; Vuillermoz I; Vieux C; Mrani S; Guillaud O; Trepo C; Zoulim F
J Clin Virol; 2005 Jun; 33(2):150-7. PubMed ID: 15911431
[TBL] [Abstract][Full Text] [Related]
18. Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.
Chen RY; Bowden S; Desmond PV; Dean J; Locarnini SA
J Gastroenterol Hepatol; 2003 Jun; 18(6):630-7. PubMed ID: 12753143
[TBL] [Abstract][Full Text] [Related]
19. [Polyarteritis nodosa: differential diagnostics and therapy].
Schirmer JH; Holl-Ulrich K; Moosig F
Z Rheumatol; 2014 Dec; 73(10):917-26; quiz 926-7. PubMed ID: 25391370
[TBL] [Abstract][Full Text] [Related]
20. Hypertensive crisis, hepatitis B virus and polyarteritis nodosa in a child.
Belot A; Ranchin B; Canterino I; Trepo C; Dubourg L; Cochat P
Pediatr Nephrol; 2007 Jan; 22(1):97-100. PubMed ID: 17106693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
